Aidoc Raises $150M Series E Led by Goldman Sachs to Scale Clinical AI Foundation Model
Tags AI · Health Tech · Enterprise
Aidoc raised $150M in Series E funding led by Growth Equity at Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Vision Fund 2, and NVentures (NVIDIA's VC arm), bringing total funding to over $500M. Aidoc's CARE clinical foundation model received FDA clearance earlier in 2026 for comprehensive triage in clinical imaging. The company analyzes more than 60 million patient cases annually and is deployed across nearly 2,000 hospitals. Funding will accelerate comprehensive disease coverage targeting pixel-to-draft-report within two years.
Technical significance
Aidoc's $500M+ total funding and deployment across 2,000 hospitals makes it one of the most scaled clinical AI companies. The Goldman Sachs-led round with NVIDIA participation signals that clinical AI is entering the infrastructure investment phase. The 'pixel-to-draft-report' vision, if realized, would fundamentally change radiology workflow by automating the entire imaging interpretation pipeline.